RT Journal Article
SR Electronic
T1 What proportion of patients with myocardial infarction are suitable for thrombolysis?
JF British Heart Journal
JO Heart
FD BMJ Publishing Group Ltd and British Cardiovascular Society
SP 144
OP 147
DO 10.1136/hrt.57.2.144
VO 57
IS 2
A1 Murray, N
A1 Lyons, J
A1 Layton, C
A1 Balcon, R
YR 1987
UL http://heart.bmj.com/content/57/2/144.abstract
AB Four hundred and three patients were considered for entry into a trial of intravenous streptokinase in suspected myocardial infarction. Three hundred and sixty seven (91%) were excluded. Two hundred and sixty (65%) did not meet the inclusion criteria and 45 of the remaining 143 (35%) patients had contraindications to thrombolysis. This left 98 (24%) patients who were suitable for thrombolysis and 42 of them were over 70 years, the upper age limit. Thus according to this trial protocol 56 (14%) patients were eligible for recruitment; 36 (9%) patients were finally randomised. These data suggest that treatment with intravenous streptokinase may be applicable to only a small proportion of patients with myocardial infarction.